Renibus Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- September 12, 2023
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $72,000,000
Company Info
- Founders
- Frank Stonebanks
- Company Description
- Renibus Therapeutics is a clinical-stage biotech company that focuses on preventing and treating kidney disease.
- Market
- Cardiorenal and metabolic diseases
- Location
- Southlake, Texas, USA